American Well Corporation — Company profile
Healthcare · Health Information Services · United States
Last price 14.98 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 254.79M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Details
| Name | American Well Corporation |
| Sector | Healthcare |
| Industry | Health Information Services |
| Employees | 562 |
| Founded | 2006 |
| Ipo Date | 2020-09-17 |
| Ceo | Ido Schoenberg |
| Country | United States |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 18.00 |
| Isin | US03044L2043 |
| Cusip | 03044L204 |
| Cik | 1393584 |
| Sic | 7389 |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Dr. Ido Schoenberg M.D. | Chairman and Chief Executive Officer |
| Mark J. Hirschhorn CPA | Executive Vice President, Chief Operating Officer and Chief Financial Officer |
| Dan Zamansky | Chief Product and Technology Officer |
| Paul Francis McNeice | Vice President of Accounting |
| Anna Nesterova | Head of Legal and Deputy General Counsel |
| Michael Miller | Senior Vice President and Chief Sales Officer |
| Phyllis I. Gotlib | President of Amwell International |
| Dr. Cynthia Horner FAAFP, M.D. | Chief Medical Officer and President of Amwell Medical Group |
Contact
| Address | 75 State Street, 26th Floor, Boston, Massachusetts 02109, United States |
| Phone | 617 204 3500 |
| Website | https://business.amwell.com |